DOPA as anti-metabolite in Huntington's disease.
D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D004156:Catechol Oxidase / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D006892:Hydroxydopamines / Q000627:therapeutic use
D006892:Hydroxydopamines; D004295:Dihydroxyphenylalanine; D004156:Catechol Oxidase; D004298:Dopamine